Jump to content

Page values for "Aripiprazole"

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringAripiprazole
brandStringAbilify (oral), Abilify Maintena (monthly IM LAI), Aristada (aripiprazole lauroxil IM LAI), Abilify Asimtufii (bi-monthly IM LAI), Abilify MyCite (digital ingestion sensor)
structureFile
classesList of String, delimiter: ,[[:Category:Neuroleptics|Neuroleptic]] [[:Category:Atypical neuroleptics|Atypical neuroleptic]] [[:Category:Third-generation neuroleptics|Third-generation neuroleptic]] [[:Category:Mood stabilizers|Mood stabilizer]]
mechanismString
usesString'"`UNIQ--vote-0000001D-QINU`"', '"`UNIQ--vote-0000001E-QINU`"', '"`UNIQ--vote-0000001F-QINU`"', '"`UNIQ--vote-00000020-QINU`"', '"`UNIQ--vote-00000021-QINU`"', '"`UNIQ--vote-00000022-QINU`"'
starting_doseStringSchizophrenia/bipolar mania: 10-15 mg PO once daily, target 15-30 mg. MDD adjunct: 2-5 mg/day, target 5-15 mg. Pediatric autism irritability: 2 mg, titrate to 5-15 mg. Maintena LAI: 400 mg IM every 4 weeks after oral overlap
preparationsStringTablets 2, 5, 10, 15, 20, 30 mg; ODT 10, 15 mg; oral solution 1 mg/mL; acute IM injection 9.75 mg/1.3 mL; Maintena LAI 300, 400 mg monthly; Aristada LAI 441, 662, 882, 1064 mg (4-8 week dosing); Asimtufii bi-monthly
fda_maxString30 mg/day (adult schizophrenia); 15 mg/day (MDD adjunct)
pill_idText
routesList of String, delimiter: ,Oral intramuscular (acute and long-acting)
onsetStringNeuroleptic effect emerges over days to weeks; activation symptoms (akathisia, insomnia) often within days
durationString24 hours (oral); 4-8 weeks (LAI)
halflifeString~75 hours (long, accumulates over weeks)'"`UNIQ--ref-00000023-QINU`"'
bioavailabilityString~87% (oral)'"`UNIQ--ref-00000024-QINU`"'
pregnancyStringLimited human data; signal for neonatal extrapyramidal symptoms and withdrawal with third-trimester exposure.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup>
legalString